Pfizer Agrees To Pay Nearly $60M To Resolve False Claims Allegations Relating To Improper Physician Payments By Subsidiary
The United States Department of Justice announced on January 24, 2025 that that pharmaceutical company Pfizer Inc. (“Pfizer”), on behalf of its wholly-owned subsidiary Biohaven Pharmaceutical Holding Company Ltd. (“Biohaven”), has agreed to pay $59,746,277 to resolve allegati[...]
